EYPT FY 2021 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$37M+7.3% YoY

Gross Profit

$29M77.9% margin

Operating Income

-$55M-149.6% margin

Net Income

-$58M-158.1% margin

EPS (Diluted)

$-2.03

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$263M

Total Liabilities

$79M

Stockholders' Equity

$184M

Cash & Equivalents

$179M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$34M	+7.3%
Gross Profit	$29M	$29M	+0.5%
Operating Income	-$55M	-$37M	-48.2%
Net Income	-$58M	-$45M	-28.7%